Search research articles
Contact Us
Filters
Showing results (491-500 of 721) with videos related to
Page
of 73
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study
Katja Ott, Ken Herrmann, Florian Lordick, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Lale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 1, 2021
<sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
Joseph G Crompton, Wesley R Armstrong, Mark A Eckardt, et al.
La Radiologia Medica
|
August 28, 2025
Recent advances in PET/MR imaging for head and neck tumors: a systematic review of the last three years
Daniele Antonio Pizzuto, Minerva Becker, Patrick Veit-Haibach, et al.
Annals of Clinical and Translational Neurology
|
September 15, 2017
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study
Joachim Brumberg, Sebastian Küsters, Ehab Al-Momani, et al.
Cancers
|
March 29, 2023
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer
Kai Jannusch, Ann-Kathrin Bittner, Nils Martin Bruckmann, et al.
Theranostics
|
July 1, 2024
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?
Alina T Küper, David Kersting, Tugce Telli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 25, 2025
Thyroid Hormone Withdrawal Yields Higher <sup>131</sup>I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large <sup>124</sup>I PET/CT Dosimetry Cohort
Ieva Čiučiulkaitė, Giulia A Zuccotti, Cherbel Jallo, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2021
Impact of EBUS-TBNA in addition to [<sup>18</sup>F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Nuklearmedizin. Nuclear Medicine
|
June 17, 2020
[Structured reporting in oncologic hybrid imaging: a consensus recommendation]
Thorsten Derlin, Sergios Gatidis, Bernd Joachim Krause, et al.
Page
of 73
Search research articles
Search
Showing results (491-500 of 721) with videos related to
Sort By:
Page
of 73
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study
Katja Ott, Ken Herrmann, Florian Lordick, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Lale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 1, 2021
<sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
Joseph G Crompton, Wesley R Armstrong, Mark A Eckardt, et al.
La Radiologia Medica
|
August 28, 2025
Recent advances in PET/MR imaging for head and neck tumors: a systematic review of the last three years
Daniele Antonio Pizzuto, Minerva Becker, Patrick Veit-Haibach, et al.
Annals of Clinical and Translational Neurology
|
September 15, 2017
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study
Joachim Brumberg, Sebastian Küsters, Ehab Al-Momani, et al.
Cancers
|
March 29, 2023
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer
Kai Jannusch, Ann-Kathrin Bittner, Nils Martin Bruckmann, et al.
Theranostics
|
July 1, 2024
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?
Alina T Küper, David Kersting, Tugce Telli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 25, 2025
Thyroid Hormone Withdrawal Yields Higher <sup>131</sup>I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large <sup>124</sup>I PET/CT Dosimetry Cohort
Ieva Čiučiulkaitė, Giulia A Zuccotti, Cherbel Jallo, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2021
Impact of EBUS-TBNA in addition to [<sup>18</sup>F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Nuklearmedizin. Nuclear Medicine
|
June 17, 2020
[Structured reporting in oncologic hybrid imaging: a consensus recommendation]
Thorsten Derlin, Sergios Gatidis, Bernd Joachim Krause, et al.
Page
of 73